Despite following the same basic recommendations as the adult guidelines, the pediatric LN guidelines included special ...

GLP-1 receptor agonist use is associated with benefits in a number of different disease and may help treat patients with lupus nephritis.

Palleon Pharmaceuticals and Shanghai Henlius Biotech have entered a licence agreement and partnership for the former’s ...

Isotopia is proud to announce a groundbreaking partnership with LIVEKIDNEY.BIO, a clinical-stage biotech innovator, to ...

The ACR has released a summary of a new 2024 guideline for the screening, treatment, and management of Lupus Nephritis.

ACR 2024 highlighted new guidelines for the screening, treatment, and management of lupus nephritis, stressing prompt kidney biopsy and timely treatment.

The following is a summary of “Efficacy and safety of guselkumab in patients with active lupus nephritis: results from a ...

Discover how the emerging field of using CAR-T cell therapy to treat lupus could offer a potential cure for the autoimmune ...

GLP-1 RAs might lower kidney failure risk in patients with lupus nephritis by reducing pro-inflammatory mediators. Glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment in patients with ...